This is a Validated Antibody Database (VAD) review about human nicotinamide N methyltransferase, based on 4 published articles (read how Labome selects the articles), using nicotinamide N methyltransferase antibody in all methods. It is aimed to help Labome visitors find the most suited nicotinamide N methyltransferase antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Santa Cruz Biotechnology
mouse monoclonal (G-4) |
| Santa Cruz Biotechnology nicotinamide N methyltransferase antibody (Santa Cruz, sc-376048) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2b) and in western blot on human samples at 1:1000 (fig 2f, e4f, e10g). Nature (2019) ncbi |
mouse monoclonal (G-4) |
| In order to understand the role of nicotinamide metabolism in the maintenance of glioblastoma stem cells, Santa Cruz Biotechnology nicotinamide N methyltransferase antibody (Santa Cruz, sc-376048) was used in immunohistochemistry - frozen section on human samples (fig 1d). JCI Insight (2017) ncbi |
Abcam
domestic rabbit polyclonal |
| Abcam nicotinamide N methyltransferase antibody (Abcam, ab58743) was used in western blot on human samples at 1:500 (fig 3i). Nat Commun (2019) ncbi |
domestic rabbit polyclonal |
| In order to understand the role of nicotinamide metabolism in the maintenance of glioblastoma stem cells, Abcam nicotinamide N methyltransferase antibody (Abcam, ab58743) was used in western blot on human samples (fig 5d). JCI Insight (2017) ncbi |
Novus Biologicals
mouse monoclonal (OTI3D8) |
| Novus Biologicals nicotinamide N methyltransferase antibody (Novus Biologicals, NBP2-00537) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1d). Oncotarget (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments